Search results
9,154 Shares in GSK plc (NYSE:GSK) Bought by Virtu Financial LLC
ETF DAILY NEWS· 5 hours agoVirtu Financial LLC acquired a new position in shares of GSK plc (NYSE:GSK – Free Report) in the fourth quarter, according to its most recent 13F filing ...
Leo Wealth LLC Purchases New Shares in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 2 days agoLeo Wealth LLC purchased a new stake in GSK plc (NYSE:GSK – Free Report) during the 4th quarter, according to the company in its most recent filing with ...
GSK (LON:GSK) Given Underweight Rating at JPMorgan Chase & Co.
ETF DAILY NEWS· 1 day agoJPMorgan Chase & Co. reissued their underweight rating on shares of GSK (LON:GSK – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com ...
The heartburn drug giving British pharma giant GSK a $3bn headache
The Telegraph via Yahoo Finance· 4 days agoAs Dame Emma Walmsley stood up to deliver GSK’s latest set of results last month, she was brimming...
iTeos Therapeutics and GSK begin Phase III trial of combination therapy for NSCLC
Clinical Trials Arena via Yahoo Finance· 2 days agoiTeos Therapeutics and GSK have begun the GALAXIES Lung-301 Phase III clinical trial of belrestotug...
As big pharma exits Nigeria, asthma patients face spiralling costs
Al Jazeera· 23 hours agoWhen Gloria Mofifoluwa’s friend informed her in March that the price of inhalers had risen in...
GSK and Ochre Bio link to explore liver disease drivers
Pharmaceutical Technology via Yahoo Finance· 7 days agoGSK has entered into a multi-year data licence agreement with Ochre Bio, aiming to advance the...
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs - Innoviva (NASDAQ:INVA)
Benzinga· 2 days agoCantor Fitzgerald has initiated coverage on Innoviva, Inc. INVA, citing the company’s unique...
Actuate Therapeutics (ACTU) to Raise $50 Million in IPO
ETF DAILY NEWS· 9 hours agoActuate Therapeutics (ACTU) plans to raise $50 million in an initial public offering on the week of...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks· 1 day agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face the FDA's partial clinical hold following the death of two patients.